Ausgabe 3/2019
Inhalt (6 Artikel)
Lung Cancer (HA Wakelee, Section Editor)
Malignant Pleural Mesothelioma: Is Tailoring the Second-Line Therapy Really “Raising the Bar?”
Vincenzo Di Noia, Emanuele Vita, Miriam Ferrara, Antonia Strippoli, Michele Basso, Giovanni Schinzari, Alessandra Cassano, Emilio Bria, Carlo Barone, Ettore D’Argento
Lung Cancer (HA Wakelee, Section Editor)
The Role of Angiogenesis Inhibitors in the Era of Immune Checkpoint Inhibitors and Targeted Therapy in Metastatic Non-Small Cell Lung Cancer
Kirstin Perdrizet, Natasha B. Leighl
Neuro-oncology (GJ Lesser, Section Editor)
Current Treatment Options for Breast Cancer Brain Metastases
Arrvind Raghunath, Kunal Desai, Manmeet S. Ahluwalia
Open Access
Neuro-oncology (GJ Lesser, Section Editor)
Current State of Immunotherapy for Treatment of Glioblastoma
Tresa McGranahan, Kate Elizabeth Therkelsen, Sarah Ahmad, Seema Nagpal
Head and Neck Cancer (CP Rodriguez, Section Editor)
Postoperative Treatment of Oropharyngeal Cancer in the Era of Human Papillomavirus
Jessica L. Geiger, Jamie A. Ku
Skin Cancer (T Ito, Section Editor)
The Potential of Targeting P53 and HSP90 Overcoming Acquired MAPKi-Resistant Melanoma
Chi-Che Hsieh, Che-Hung Shen